After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.
Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...
The White Houes may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback